Translational scientist Jacqueline Achkar of Albert Einstein Medical College will lead several collaborations to build a point-of-care diagnostic platform.
In PNAS this week: bottleneck sequencing system, dromedary camel coronaviruses, and more.
The partnership is part of a broader agreement between Genome BC and Genomics England to share data and tools around cancer and rare and infectious diseases.
In PLOS this week: statistical method for prioritizing candidate genes, apple chorotic leaf spot virus sequence, and more.
New research shows early man's use of fire may have triggered mutations that contributed to human evolution.
Longhorn Vaccines and Diagnostics' one-step reagent for sample collection and transport enhanced M. tuberculosis detection on the Xpert MTB/RIF assay.
In PLOS this week: genetic characterization of lager yeast, phylogenetic study of Rickettsia africae, and more.
The deal gives Oxford access to Imugen’s Lyme disease tests as well as PCR and immunoassay tests.
The firm expands its portfolio, providing customers with Dx for multiple applications
The test, which uses melt curve analysis and runs on a fully integrated platform from Zeesan, may have a head start on MDR and XDR tests from other companies.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.